Penta Valent

JKT:PEVE · ID1000183601

Health Care Providers & ServicesSmall

360

Medium confidence — indicative

Value63

Profit price53

Cash yield35

Owner Earnings Yield69

Dividend Yield1

Sales & asset price77

Price/Sales100

EV / Gross Profit73

Price/Book58

Quality40

Returns on capital79

Return on Capital81

Cash Return on Capital67

Return on Equity88

Profit margins45

EBIT Margin28

Gross Profitability61

Cash backing15

Cash Conversion1

Accruals4

Owner Earnings Margin39

Growth37

Sales growth33

Profit growth42

Profit Growth49

Long-Term EPS Growth37

Owner Earnings Growth39

Reinvestment41

Price momentum33

Safety33

Debt load11

Debt serviceability69

Refinancing99

Debt Payback38

Liquidity26

Sentiment47

Analyst ratings—

Expectations trend—

Market mood3

Value Creation12/20creating some value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Penta Valent clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIndonesia

IndustryHealth Care Providers & Services

SizeSmall

TypePublic Company

ExchangeIDX

Employees122

Websitepentavalent.co.id

ISINID1000183601

Last UpdateApr 2, 2026

Indices

IDX Composite (Indonesia)

Themes

NutraceuticalHealth DiagnosticsDermatologyFast-Moving Consumer GoodsHealth CareMedical DevicePharmaceuticalWholesale

Description

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. Business Segments The company primarily classifies its business activities into two core segments: Pharmaceutical Products This segme…

Analysis

Middle-of-the-road

PT. Penta Valent Tbk sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is attractive. The owner-earnings multiple stands at 8.8×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

100

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Penta Valent with its peers

Medeze

SET:MEDEZE

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Advice IT Infinite

SET:ADVICE

CountryThailand

IndustrySpecialty Retail

SizeSmall

Full Stock Analysis →

Saraswanti Anugerah Makmur

JKT:SAMF

CountryIndonesia

IndustryChemicals

SizeSmall

Full Stock Analysis →

Mega Lifesciences

SET:MEGA

CountryThailand

IndustryPharmaceuticals

SizeMedium

Full Stock Analysis →

Sejahteraraya Anugrahjaya

JKT:SRAJ

CountryIndonesia

IndustryHealth Care Providers & Services

SizeMedium

Full Stock Analysis →

Alps Group

NMQ:ALPS

CountryMalaysia

IndustryBiotechnology

SizeX-Small

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →